About Drug Development Solutions

We help develop new medicines and products to improve the quality of life

Drug Development Solutions is a contract research organisation (CRO) offering GLP and GCP bioanalysis of small molecules, large proteins for pharmacokinetics, biomarkers and immunogenicity.

We also provide cGMP analytical sciences research and testing services, consultancy and quality control solutions to support Chemistry, Manufacturing, and Controls (CMC) requirements at all stages of the drug development pipeline from discovery through preclinical and clinical development to commercial manufacture.

About Alliance Pharma, Inc

Alliance Pharma is a Contract Research Organization (CRO) specialising in Drug Metabolism and Pharmacokinetics (DMPK) and bioanalytical services for both small and large molecules

Drug Development Solutions used to be part of the LGC Group, being sold in July 2022.

Read more about the sale of Drug Development Solutions to Alliance Pharma 

Our Drug Development Solutions' team provides:

Bioanalytical Solutions include liquid-chromatography mass spectrometry (LC-MS) and immunoassay bioanalysis, to provide data for pharmacokinetics, immunogenicity, pharmacodynamics and cell-based assays supporting all phases of drug development to GCP and GLP standards.

Our Analytical Materials Science Solutions provides specialist testing of raw materials, formulated products, packaging and medical devices for trace impurities, contamination, degradation and quality control to support CMC (Chemistry Control and Manufacture) analytical testing to GMP (Good Manufacturing Practice) standard.

The Alliance Pharma team specialise in Drug Metabolism and Pharmacokinetic (DMPK) and bioanalytical services for both small and large molecules.